English | Español

Merck
Carol Ostrow | May 16, 2018

FDA accepts two new drug applications for Merck HIV-1 therapy
Marian Johns | Jan 17, 2018

FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer
Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval
Carol Ostrow | Oct 15, 2017

Merck KGaA aims raise awareness, boost support for unpaid caregivers
Carol Ostrow | Oct 1, 2017

Merck to host meeting on third-quarter performance
Russell Boniface | Sep 13, 2017

Merck's Keytruda wins European approval as bladder cancer treatment

Robert Hadley | Jun 16, 2017

Merck’s Keytruda shown effective in treating aggressive form of breast cancer
Tabitha Fleming | Jun 2, 2017

Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe

Trending
+ Pharmaceuticals
Patient Daily | Dec 20, 2024

Discovery of replication hubs may lead to new antiviral therapies for norovirus
Patient Daily | Dec 23, 2024

Patient Advocacy Group: ‘Policymakers must remove barriers to the development and delivery of innovative’ health care
+ Pharmaceuticals
Patient Daily | Dec 17, 2024

Lung association warns against combined risks of smoking and radon
+ Pharmaceuticals
Patient Daily | Dec 20, 2024

California student returns home after receiving life-saving heart transplant